Silverman Joshua
Insider CIK 1524858 · MGT · ATRN Director · NHLD Director · TWFH 10% owner · FABC Executive Chairman, Director · TPIV Director · PMCB Interim CEO, Interim President, Director · QCLS Executive Chairman, Director · FEMY Director · NTRP Director · SNPX Executive Chairman, Director · PTPI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2026-10-01 | 2026-10-02 | 77,390 | — | $0 | 210,845 | SEC↗ |
| FABC Fabric.AI, Inc. | F Tax w/h | 2026-09-30 | 2026-10-16 | 44,820 | $2.28 | $102.2K | 235,937 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2026-07-10 | 2026-10-02 | 16,620 | — | $0 | 133,455 | SEC↗ |
| FABC Fabric.AI, Inc. | F Tax w/h | 2026-06-30 | 2026-08-14 | 44,820 | $3.69 | $165.4K | 280,757 | SEC↗ |
| FABC Fabric.AI, Inc. | F Tax w/h | 2026-06-30 | 2026-08-14 | 44,820 | $3.69 | $165.4K | 280,757 | SEC↗ |
| FABC Fabric.AI, Inc. | A Award | 2026-06-18 | 2026-08-14 | 358,565 | — | $0 | 370,397 | SEC↗ |
| FABC Fabric.AI, Inc. | F Tax w/h | 2026-06-18 | 2026-08-14 | 44,820 | $3.70 | $165.8K | 325,577 | SEC↗ |
| FABC Fabric.AI, Inc. | F Tax w/h | 2026-06-18 | 2026-08-14 | 44,820 | $3.70 | $165.8K | 325,577 | SEC↗ |
| FABC Fabric.AI, Inc. | A Award | 2026-06-18 | 2026-08-14 | 358,565 | — | $0 | 370,397 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award | 2026-06-05 | 2026-06-05 | 4,375,000 | — | $0 | 8,790,450 | SEC↗ |
| TAOX TAO Synergies Inc. | A Award deriv | 2026-05-18 | 2026-05-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award deriv | 2026-04-13 | 2026-04-15 | 100,000 | — | $0 | 50,000 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2026-04-13 | 2026-04-15 | 162,162 | — | $0 | 262,191 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award deriv | 2026-04-13 | 2026-10-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2026-04-13 | 2026-10-02 | 16,806 | — | $0 | 116,835 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | P Buy | 2026-01-07 | 2026-01-07 | 40,000 | $0.83 | $33.2K | 416,250 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | P Buy | 2026-01-06 | 2026-01-07 | 30,000 | $0.79 | $23.7K | 376,250 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | P Buy | 2026-01-05 | 2026-01-07 | 30,000 | $0.78 | $23.4K | 346,250 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award | 2026-01-02 | 2026-01-02 | 4,375,000 | — | $0 | 4,415,450 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | F Tax w/h | 2025-12-12 | 2025-12-12 | 258,750 | $1.02 | $263.9K | 316,250 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | A Award | 2025-12-12 | 2025-12-12 | 575,000 | — | $0 | 575,000 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2025-11-14 | 2025-11-14 | 91,356 | — | $0 | 100,029 | SEC↗ |
| SBLX StableX Technologies, Inc. | A Award deriv | 2025-10-31 | 2025-10-31 | 220,513 | — | $0 | 220,513 | SEC↗ |
| TAOX TAO Synergies Inc. | F Tax w/h | 2025-10-17 | 2025-10-17 | 40,000 | $7.23 | $289.2K | 86,681 | SEC↗ |
| TAOX TAO Synergies Inc. | A Award | 2025-10-17 | 2025-10-17 | 100,000 | — | $0 | 126,681 | SEC↗ |
| QCLS Q/C TECHNOLOGIES, INC. | A Award | 2025-10-03 | 2025-10-06 | 8,644 | — | $0 | 8,673 | SEC↗ |
| TAOX TAO Synergies Inc. | A Award deriv | 2025-08-06 | 2025-10-17 | 36,000 | — | $0 | 36,000 | SEC↗ |
| TAOX TAO Synergies Inc. | F Tax w/h | 2025-06-30 | 2025-07-02 | 16,768 | $7.85 | $131.6K | 26,681 | SEC↗ |
| TAOX TAO Synergies Inc. | A Award | 2025-06-30 | 2025-07-02 | 41,919 | — | $0 | 43,449 | SEC↗ |
| FEMY FEMASYS INC | A Award deriv | 2025-06-25 | 2025-06-27 | 17,600 | — | $0 | 17,600 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award | 2025-02-19 | 2025-02-21 | 1,000,000 | — | $0 | 1,011,237 | SEC↗ |
| AYRO AYRO, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-02 | 97,368 | — | $0 | 97,368 | SEC↗ |
| AYRO AYRO, Inc. | D To issuer | 2024-12-02 | 2024-12-02 | 6,166 | — | $0 | 43,271 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2024-12-02 | 2024-12-02 | 146,052 | — | $0 | 189,323 | SEC↗ |
| FEMY FEMASYS INC | A Award deriv | 2024-07-12 | 2024-07-15 | 17,600 | — | $0 | 17,600 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 800 | — | $0 | 800 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2023-12-21 | 2023-12-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FEMY FEMASYS INC | A Award deriv | 2023-11-21 | 2023-11-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PMCB PharmaCyte Biotech, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 170,000 | — | $0 | 170,000 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2023-08-01 | 2023-08-03 | 12,740 | $0.82 | $10.4K | 395,493 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2023-05-03 | 2023-05-05 | 11,927 | $0.49 | $5.8K | 408,233 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | M Exercise deriv | 2023-04-26 | 2023-04-28 | 6,722 | — | $0 | 0 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | M Exercise | 2023-04-26 | 2023-04-28 | 6,722 | — | $0 | 11,237 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2023-04-10 | 2023-04-12 | 39,000 | — | $0 | 39,000 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2023-02-01 | 2023-02-03 | 197,333 | — | $0 | 420,160 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2023-01-30 | 2023-02-03 | 7,171 | $0.71 | $5.1K | 222,827 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | M Exercise deriv | 2023-01-20 | 2023-01-25 | 2,515 | — | $0 | 0 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | M Exercise | 2023-01-20 | 2023-01-25 | 2,515 | — | $0 | 4,515 | SEC↗ |
| SNPX Synaptogenix, Inc. | S Sale | 2022-12-16 | 2022-12-20 | 19,012 | $1.17 | $22.2K | 38,238 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award deriv | 2022-11-15 | 2022-11-17 | 144,000 | — | $0 | 144,000 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award deriv | 2022-11-15 | 2022-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2022-11-01 | 2022-11-03 | 7,171 | $0.59 | $4.2K | 229,998 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2022-05-11 | 2022-11-03 | 12,855 | $0.82 | $10.5K | 237,169 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2022-04-07 | 2022-04-11 | 67,227 | — | $0 | 67,227 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award deriv | 2022-04-05 | 2022-04-06 | 1,500 | — | $0 | 1,500 | SEC↗ |
| SNPX Synaptogenix, Inc. | J Other deriv | 2022-04-05 | 2022-06-23 | 0 | — | $0 | 0 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2022-02-01 | 2022-02-03 | 114,729 | — | $0 | 250,024 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2021-12-22 | 2022-01-07 | 25,156 | — | $0 | 25,156 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | P Buy | 2021-11-26 | 2021-11-29 | 5,000 | $7.55 | $37.8K | 88,775 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | P Buy | 2021-11-24 | 2021-11-29 | 6,734 | $6.30 | $42.4K | 80,509 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | P Buy | 2021-11-24 | 2021-11-29 | 3,266 | $7.09 | $23.2K | 83,775 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | A Award deriv | 2021-10-14 | 2021-10-15 | 600,000 | — | $0 | 600,000 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award | 2021-07-13 | 2022-12-01 | 42,250 | — | $0 | 57,250 | SEC↗ |
| SNPX Synaptogenix, Inc. | A Award | 2021-07-13 | 2021-07-15 | 90,000 | — | $0 | 105,000 | SEC↗ |
| SNPX Synaptogenix, Inc. | P Buy | 2021-06-14 | 2021-06-16 | 10,000 | $8.30 | $83.0K | 15,000 | SEC↗ |
| AYRO AYRO, Inc. | S Sale | 2021-06-04 | 2021-06-08 | 39,008 | $5.17 | $201.7K | 135,295 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | M Exercise deriv | 2021-04-16 | 2021-04-20 | 109,500 | — | $0 | 0 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | M Exercise | 2021-04-16 | 2021-04-20 | 109,500 | — | $0 | 112,101 | SEC↗ |
| MYMD MyMD Pharmaceuticals, Inc. | F Tax w/h | 2021-04-16 | 2021-04-20 | 38,325 | $4.94 | $189.3K | 71,175 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2021-04-08 | 2021-04-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2021-02-24 | 2021-02-26 | 42,000 | — | $0 | 174,303 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 24,855 | — | $0 | 24,855 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 1,875 | — | $0 | 1,875 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 33,400 | — | $0 | 33,400 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award deriv | 2020-12-01 | 2020-12-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 100,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 150,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 9,375 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 124,275 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 167,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| PTPI Petros Pharmaceuticals, In | A Award | 2020-12-01 | 2020-12-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer | 2020-12-01 | 2020-12-03 | 100,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2020-11-24 | 2020-11-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 50,000 | $1.09 | $54.5K | 100,000 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy | 2020-10-15 | 2020-10-19 | 50,000 | $1.07 | $53.5K | 50,000 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2020-09-29 | 2020-10-01 | 122,547 | — | $0 | 132,303 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2020-09-29 | 2020-12-28 | 122,547 | — | $0 | 132,303 | SEC↗ |
| AKER Akers Biosciences, Inc. | A Award deriv | 2020-09-11 | 2020-09-11 | 219,000 | — | $0 | 219,000 | SEC↗ |
| AYRO AYRO, Inc. | A Award | 2020-05-28 | 2020-06-01 | 9,756 | — | $0 | 9,756 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2020-03-20 | 2020-03-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2020-02-21 | 2020-02-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AKER Akers Biosciences, Inc. | M Exercise deriv | 2020-01-01 | 2020-01-03 | 5,201 | — | $0 | 0 | SEC↗ |
| AKER Akers Biosciences, Inc. | M Exercise | 2020-01-01 | 2020-01-03 | 5,201 | — | $0 | 5,201 | SEC↗ |
| DCAR DropCar, Inc. | F Tax w/h | 2019-08-27 | 2019-08-29 | 14,972 | $0.78 | $11.7K | 69,915 | SEC↗ |
| DCAR DropCar, Inc. | A Award | 2019-08-27 | 2019-08-29 | 75,950 | — | $0 | 84,887 | SEC↗ |
| AKER Akers Biosciences, Inc. | A Award deriv | 2019-03-29 | 2019-04-02 | 124,827 | — | $0 | 124,827 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2019-03-15 | 2019-04-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2019-02-11 | 2019-02-22 | 1,667 | — | $0 | 1,667 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2019-02-11 | 2019-02-22 | 2,223 | — | $0 | 2,223 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2019-02-11 | 2019-02-22 | 1,716 | — | $0 | 1,716 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2019-02-11 | 2019-02-22 | 1,161 | — | $0 | 1,161 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TPIV TAPIMMUNE INC. | A Award | 2018-10-16 | 2018-10-17 | 4,106 | — | $0 | 17,221 | SEC↗ |
| DCAR DropCar, Inc. | P Buy | 2018-06-26 | 2018-06-26 | 5,000 | $1.29 | $6.5K | 35,109 | SEC↗ |
| DCAR DropCar, Inc. | P Buy | 2018-06-25 | 2018-06-26 | 11,700 | $1.25 | $14.6K | 30,109 | SEC↗ |
| DCAR DropCar, Inc. | P Buy | 2018-06-22 | 2018-06-26 | 13,300 | $1.27 | $16.9K | 18,409 | SEC↗ |
| DCAR DropCar, Inc. | A Award deriv | 2018-05-14 | 2018-12-03 | 18,282 | — | $0 | 18,282 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2018-03-13 | 2018-03-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2018-02-28 | 2018-03-02 | 2,222 | — | $0 | 2,222 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2018-02-28 | 2018-03-02 | 1,716 | — | $0 | 1,716 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2018-02-28 | 2018-03-02 | 1,667 | — | $0 | 1,667 | SEC↗ |
| DCAR DropCar, Inc. | J Other deriv | 2018-02-28 | 2018-03-02 | 1,161 | — | $0 | 1,161 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 31,093 | — | $0 | 31,093 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 41,667 | — | $0 | 41,667 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 49,167 | — | $0 | 49,167 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 10,574 | — | $0 | 10,574 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 41,667 | — | $0 | 41,667 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other deriv | 2018-02-28 | 2018-03-02 | 44,000 | — | $0 | 44,000 | SEC↗ |
| DCAR DropCar, Inc. | J Other | 2018-02-28 | 2018-03-02 | 5,109 | — | $0 | 5,109 | SEC↗ |
| TPIV TAPIMMUNE INC. | J Other | 2018-02-28 | 2018-03-02 | 153,333 | — | $0 | 153,333 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2017-10-16 | 2017-10-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TPIV TAPIMMUNE INC. | A Award | 2017-08-29 | 2017-08-30 | 13,115 | — | $0 | 13,115 | SEC↗ |
| WPCS WPCS INTERNATIONAL INC | A Award deriv | 2017-04-28 | 2017-05-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2017-04-11 | 2017-04-13 | 167,000 | — | $0 | 167,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2017-03-17 | 2017-03-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TPIV TAPIMMUNE INC | A Award deriv | 2016-11-28 | 2016-11-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2016-11-21 | 2016-11-23 | 3,976,767 | — | $0 | 3,976,767 | SEC↗ |
| NHLD NATIONAL HOLDINGS CORP | U Tender | 2016-09-12 | 2016-09-13 | 414,323 | $3.25 | $1.35M | 414,323 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2016-08-04 | 2016-08-19 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2016-08-04 | 2016-08-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATRN Protagenic Therapeutics, I | A Award | 2016-06-17 | 2016-06-21 | 45,000 | $1.25 | $56.3K | 45,000 | SEC↗ |
| TWFH 24HOLDINGS INC | P Buy | 2013-05-09 | 2013-05-14 | 344,210 | $0.19 | $65.4K | 693,558 | SEC↗ |